
The drug, sarilumab, sold as Kevzara, didn’t show benefits to patients who were hospitalized but not on ventilators. The study will continue with critically ill patients.
By BY GINA KOLATA from NYT Health https://ift.tt/2W8RAts
via IFTTT
your-feed-science, Drugs (Pharmaceuticals), Coronavirus (2019-nCoV), Clinical Trials, your-feed-healthcare
Source New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét